| Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, M Zappa, V Nelen, ... The Lancet 384 (9959), 2027-2035, 2014 | 1884 | 2014 |
| A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer J Hugosson, MJ Roobol, M Månsson, TLJ Tammela, M Zappa, V Nelen, ... European urology 76 (1), 43-51, 2019 | 534 | 2019 |
| Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review D Puliti, SW Duffy, G Miccinesi, H De Koning, E Lynge, M Zappa, E Paci Journal of medical screening 19 (1_suppl), 42-56, 2012 | 532 | 2012 |
| Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi, F Falaschi, F Pistelli, ... Thorax 72 (9), 825-831, 2017 | 299 | 2017 |
| Metastatic prostate cancer incidence and prostate-specific antigen testing: new insights from the European Randomized Study of Screening for Prostate Cancer C Buzzoni, A Auvinen, MJ Roobol, S Carlsson, SM Moss, D Puliti, ... European urology 68 (5), 885-890, 2015 | 156 | 2015 |
| European breast cancer service screening outcomes: a first balance sheet of the benefits and harms E Paci, M Broeders, S Hofvind, D Puliti, SW Duffy, ... Cancer epidemiology, biomarkers & prevention 23 (7), 1159-1163, 2014 | 125 | 2014 |
| Reproducibility of HPV DNA testing by Hybrid Capture 2 in a screening setting: intralaboratory and interlaboratory quality control in seven laboratories participating in the … FM Carozzi, AD Mistro, M Confortini, C Sani, D Puliti, R Trevisan, ... American journal of clinical pathology 124 (5), 716-721, 2005 | 119 | 2005 |
| Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy E Paci, G Miccinesi, D Puliti, P Baldazzi, V De Lisi, F Falcini, C Cirilli, ... Breast Cancer Research 8, 1-9, 2006 | 110 | 2006 |
| Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction D Puliti, G Miccinesi, N Collina, V De Lisi, M Federico, S Ferretti, ... British journal of cancer 99 (3), 423-427, 2008 | 103 | 2008 |
| An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence D Puliti, M Zappa, G Miccinesi, P Falini, E Crocetti, E Paci European journal of cancer 45 (18), 3166-3171, 2009 | 84 | 2009 |
| Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting FM Carozzi, E Burroni, S Bisanzi, D Puliti, M Confortini, P Giorgi Rossi, ... Journal of clinical microbiology 49 (4), 1446-1451, 2011 | 72 | 2011 |
| Decreasing incidence of late‐stage breast cancer after the introduction of organized mammography screening in Italy F Foca, S Mancini, L Bucchi, D Puliti, M Zappa, C Naldoni, F Falcini, ... Cancer 119 (11), 2022-2028, 2013 | 67 | 2013 |
| Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997–2001) M Zorzi, D Puliti, M Vettorazzi, V De Lisi, F Falcini, M Federico, S Ferretti, ... British journal of cancer 95 (9), 1265-1268, 2006 | 63 | 2006 |
| Advanced breast cancer rates in the epoch of service screening: the 400,000 women cohort study from Italy D Puliti, L Bucchi, S Mancini, E Paci, S Baracco, C Campari, D Canuti, ... European Journal of Cancer 75, 109-116, 2017 | 60 | 2017 |
| Balancing harms and benefits of service mammography screening programs: a cohort study D Puliti, G Miccinesi, M Zappa, G Manneschi, E Crocetti, E Paci Breast Cancer Research 14, 1-8, 2012 | 57 | 2012 |
| Breast cancer screening: are we seeing the benefit? D Puliti, M Zappa Bmc Medicine 10, 1-4, 2012 | 51 | 2012 |
| Overdiagnosis in breast cancer: design and methods of estimation in observational studies D Puliti, G Miccinesi, E Paci Preventive medicine 53 (3), 131-133, 2011 | 51 | 2011 |
| The European randomized study of screening for prostate cancer–prostate cancer mortality at 13 years of follow-up FH Schröder, J Hugosson, MJ Roobol, TLJ Tammela, M Zappa, V Nelen, ... Lancet 384 (9959), 2027, 2014 | 50 | 2014 |
| Absolute effect of prostate cancer screening: balance of benefits and harms by center within the European Randomized Study of Prostate Cancer Screening A Auvinen, SM Moss, TLJ Tammela, K Taari, MJ Roobol, FH Schröder, ... Clinical Cancer Research 22 (1), 243-249, 2016 | 48 | 2016 |
| Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening A Caldarella, D Puliti, E Crocetti, S Bianchi, V Vezzosi, P Apicella, ... Journal of cancer research and clinical oncology 139, 181-185, 2013 | 48 | 2013 |
